Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
03/2011
03/31/2011CA2775204A1 Fused imidazo [3, 2 - d] pyraz ines as pi3 kinase inhibitors
03/31/2011CA2775133A1 Pyrido[3,4-b]indoles and methods of use
03/31/2011CA2775129A1 Pyrido[3,4-b]indoles and methods of use
03/31/2011CA2770278A1 Pyrazoline dione derivatives as nadph oxidase inhibitors
03/31/2011CA2770087A1 Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 1oa inhibitors
03/30/2011EP2301939A1 Enzyme inhibitors
03/30/2011EP2301936A1 Spirodiamine-diarylketoxime derivative
03/30/2011EP2301544A1 Quinoline derivatives as intermediates to mycobacterial inhibitors
03/30/2011EP2301541A1 Antibiotic compositions for treatment of the eye, ear and nose
03/30/2011EP2300477A1 Tricyclic nitrogen containing compounds and their use as antibacterials
03/30/2011EP2300476A1 Tricyclic nitrogen containing compounds and their use as antibacterials
03/30/2011EP2300475A1 Diazacarbazoles and methods of use
03/30/2011EP2300474A1 Spiro (piperidine-4, 2 ' -pyrrolidine) -1- (3, 5- trifluoromethyl phenyl) methylcarboxamides as nk1 tachikynin receptor antagonists
03/30/2011EP2300473A2 Fumarate salt of 4-bromophenyl 1,4-diazabicycloý3.2.2¨nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
03/30/2011EP2300472A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/30/2011EP2300471A1 Substituted pyridin-4-yl-methyl sulfonamidesas fungicides
03/30/2011EP2300470A2 Imidazo[1,2-a]pyridine compounds as gaba-a receptor modulators
03/30/2011EP2300469A2 Fused nitrogen containing heterocycles and compositions thereof as kinase inhibitors
03/30/2011EP2300468A1 Therapeutically useful substituted 1, 7-diphenyl-l, 2, 3, 5, 6, 7-hexahydropyrido ý 3, 2, 1-i j¨quinoline compounds
03/30/2011EP2300467A2 Novel and improved processes for the preparation of paliperidone
03/30/2011EP2300466A1 Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
03/30/2011EP2300465A1 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
03/30/2011EP2300440A1 3,4-dihydropyrimidine trpa1 antagonists
03/30/2011EP2300438A1 Imidazole derivatives useful as inhibitors of faah
03/30/2011EP2300436A1 Carbamoyl derivatives of bicyclic carbonylamino-pyrazoles as prodrugs
03/30/2011EP2300422A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists
03/30/2011EP2299824A1 Pyrazole derivatives useful as inhibitors of faah
03/30/2011EP2299816A1 Inhibitors of janus kinases
03/30/2011EP2299813A1 Branched 3- and 6-substituted quinolines as cgrp receptor antagonists
03/30/2011EP2176259B1 Fused imidazoles for cancer treatment
03/30/2011EP2057125B1 Non-nucleoside reverse transcriptase inhibitors
03/30/2011EP1940835B1 Pyrazolo[3,4-b]pyridine compounds, and their use as pde4 inhibitors
03/30/2011EP1804919B1 Cgrp receptor antagonists
03/30/2011EP1742927B1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
03/30/2011EP1441719B1 N-substituted pyrrolidin derivatives as dipeptidyl peptidase iv inhibitors
03/30/2011EP1277738B1 Condensed heteroaryl derivatives
03/30/2011CN101993443A Novel crystal form of benzilic acid nortropine easter and preparation method thereof
03/30/2011CN101993409A Heterocyclic compound, organic light-emitting device containing polycyclic heteroaryl compounds
03/30/2011CN101279969B Organic electroluminescent material and application thereof
03/29/2011US7915411 Anti-viral compounds
03/29/2011US7915286 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
03/29/2011US7915284 2-aryl-6-phenylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
03/29/2011US7915283 e.g. 1-[4-(1-Phenyl-1-(pyrazinyl)-methylene)-piperidin-1-yl]-2-(4-methoxy-7-pyrazinyl-6-azaindol-3-yl)-ethane-1,2-dione; viricides for prophylaxis of lympadenopathy associated virus; synergystic mixtures with immunomodulators
03/29/2011US7915281 Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
03/29/2011US7915280 Compounds and their uses
03/29/2011US7915264 Drugs for treating pain formed by arylation
03/29/2011US7914908 Organic electroluminescent device having an azatriphenylene derivative
03/29/2011US7914706 Charge transport compositions and electronic devices made with such compositions
03/29/2011US7914703 exhibit high fluorescence in inks; useful for security taggant applications
03/29/2011CA2543250C Process for the preparation of ccr-2 antagonist
03/29/2011CA2489276C Tricyclic steroid hormone nuclear receptor modulators
03/29/2011CA2483752C Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
03/29/2011CA2462211C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
03/29/2011CA2443672C Aryl and biaryl piperidines used as mch antagonists
03/29/2011CA2436980C Amido ether substituted imidazoquinolines
03/29/2011CA2434616C (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof
03/29/2011CA2428223C Compounds and methods for promoting smoking cessation
03/24/2011WO2011034954A1 Treatment of cancer
03/24/2011WO2011034215A1 COMPOUNDS HAVING TAFIa INHIBITORY ACTIVITY
03/24/2011WO2011034078A1 Glycine compound
03/24/2011WO2011033230A1 5-phenyl pyrazolopyridine derivatives, preparation and therapeutic use thereof
03/24/2011WO2011033229A1 Acetylene derivatives of 5-phenyl-pyrazolopyridine, preparation thereof, and therapeutic use thereof
03/24/2011WO2011033055A1 Fused triazole amines as p2x7 modulators
03/24/2011WO2011010842A3 Novel organic electroluminescent compounds and organic electroluminescent device using the same
03/24/2011WO2011008725A3 Metal-catalyzed carbon-fluorine bond formation
03/24/2011WO2010123583A3 1-aryl or 1-heteroaryl-pyrido[b]indoles and uses thereof
03/24/2011US20110071189 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/24/2011US20110071188 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/24/2011US20110071187 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
03/24/2011US20110071180 Sub-type selective amides of diazabicycloalkanes
03/24/2011US20110071174 Substituted quinazolines
03/24/2011US20110071161 Triazolopyridine carboxamide derivatives, preparation thereof and therapeutic use thereof
03/24/2011US20110071160 1,3-DIHYDRO-2H-PYRROLO[3,2-b]PYRIDIN-2-ONE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USES THEREOF
03/24/2011US20110071155 Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials
03/24/2011US20110071148 Compounds as the estrogen related receptors modulators and the uses thereof
03/24/2011US20110071147 4-amino-thieno[3,2-c]pyridine-7-carboxylic acid amides
03/24/2011US20110071143 Fused triazole amines as p2x7 modulators
03/24/2011US20110071136 Novel tricyclic protein kinase modulators
03/24/2011US20110071131 Substituted Spirocyclic Piperidine Derivatives as Histamine-3 (H3) Receptor Ligands
03/24/2011US20110071128 Novel imidazopyridines
03/24/2011US20110070595 Methods for the identification of parp interacting molecules and for purification of parp proteins
03/24/2011US20110070317 Pyrrolopyridines as kinase inhibitors
03/24/2011US20110070297 Glucokinase activators
03/24/2011US20110068012 Biosensor and method of detection of a dna sequence
03/24/2011CA2774266A1 Novel tricyclic protein kinase modulators
03/24/2011CA2774148A1 Tricyclic compounds and pharmaceutical uses thereof
03/24/2011CA2773985A1 Protein kinase conjugates and inhibitors
03/24/2011CA2773125A1 Compounds having tafia inhibitory activity
03/24/2011CA2772689A1 Glycine compound
03/24/2011CA2772105A1 Fused triazole amines as p2x7 modulators
03/23/2011EP2299509A1 Organic electroluminescent device
03/23/2011EP2298775A1 Diazabicyclic central nervous system active agents
03/23/2011EP2298768A1 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2H-pyrido[2,3-d]pyrimidine derivatives and related compounds for the treatment of cancer
03/23/2011EP2298767A1 Nitrogenated bicyclic heterocyclic compound
03/23/2011EP2298759A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/23/2011EP2298758A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases
03/23/2011EP2298739A1 Organic light emitting device containing polycyclic heteroaryl compounds
03/23/2011EP2297274A1 Chlorinated naphthalenetetracarboxylic acid derivatives, preparation thereof and use thereof in organic electronics
03/23/2011EP2297150A1 Substituted quinazolines as blood platelet lowering agents
03/23/2011EP2297149A1 Process for preparation of tadalafil